2022
DOI: 10.1016/j.amepre.2021.09.002
|View full text |Cite
|
Sign up to set email alerts
|

Public Knowledge and Attitudes Toward Clinical Trials in the COVID-19 Era

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 9 publications
0
2
0
Order By: Relevance
“…In a study published in 2021 in the US, respondents (59%) identified physicians as their first source of information about clinical trials [22]. In another study conducted by the National Cancer Institute in the US, respondents identified a healthcare provider (73.3%) and patient organizations (13.5%) as their source of information about clinical trials [23].…”
Section: Discussionmentioning
confidence: 99%
“…In a study published in 2021 in the US, respondents (59%) identified physicians as their first source of information about clinical trials [22]. In another study conducted by the National Cancer Institute in the US, respondents identified a healthcare provider (73.3%) and patient organizations (13.5%) as their source of information about clinical trials [23].…”
Section: Discussionmentioning
confidence: 99%
“…In a study published in 2021 in the US, respondents (59.0%) identified physicians as their first source of information about clinical trials [ 24 ]. In another study conducted by the National Cancer Institute in the US, respondents identified a healthcare provider (73.3%) and patient organizations (13.5%) as their source of information about clinical trials [ 25 ].…”
Section: Discussionmentioning
confidence: 99%